1. Home
  2. LUNG vs ONL Comparison

LUNG vs ONL Comparison

Compare LUNG & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • ONL
  • Stock Information
  • Founded
  • LUNG 1995
  • ONL 2021
  • Country
  • LUNG United States
  • ONL United States
  • Employees
  • LUNG N/A
  • ONL N/A
  • Industry
  • LUNG Industrial Specialties
  • ONL Real Estate Investment Trusts
  • Sector
  • LUNG Health Care
  • ONL Real Estate
  • Exchange
  • LUNG Nasdaq
  • ONL Nasdaq
  • Market Cap
  • LUNG 248.0M
  • ONL 205.6M
  • IPO Year
  • LUNG 2020
  • ONL N/A
  • Fundamental
  • Price
  • LUNG $7.30
  • ONL $3.74
  • Analyst Decision
  • LUNG Strong Buy
  • ONL Hold
  • Analyst Count
  • LUNG 7
  • ONL 1
  • Target Price
  • LUNG $13.71
  • ONL N/A
  • AVG Volume (30 Days)
  • LUNG 237.6K
  • ONL 326.7K
  • Earning Date
  • LUNG 10-28-2024
  • ONL 11-07-2024
  • Dividend Yield
  • LUNG N/A
  • ONL 10.71%
  • EPS Growth
  • LUNG N/A
  • ONL N/A
  • EPS
  • LUNG N/A
  • ONL N/A
  • Revenue
  • LUNG $76,583,000.00
  • ONL $179,652,000.00
  • Revenue This Year
  • LUNG $22.73
  • ONL N/A
  • Revenue Next Year
  • LUNG $19.02
  • ONL N/A
  • P/E Ratio
  • LUNG N/A
  • ONL N/A
  • Revenue Growth
  • LUNG 26.26
  • ONL N/A
  • 52 Week Low
  • LUNG $5.46
  • ONL $3.01
  • 52 Week High
  • LUNG $14.84
  • ONL $6.22
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 41.60
  • ONL 39.44
  • Support Level
  • LUNG $7.18
  • ONL $3.68
  • Resistance Level
  • LUNG $8.59
  • ONL $4.25
  • Average True Range (ATR)
  • LUNG 0.40
  • ONL 0.14
  • MACD
  • LUNG -0.16
  • ONL -0.06
  • Stochastic Oscillator
  • LUNG 7.74
  • ONL 8.45

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About ONL Orion Office REIT Inc.

Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.

Share on Social Networks: